Last reviewed · How we verify
NCT04119908: VIDEO-BLEED
Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NA trial testing Sublingual videomicroscopy in Von Willebrand Diseases in 400 participants. Currently enrolling.
24 May 2028
Quick facts
| Lead sponsor | University Hospital, Lille |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 400 |
| Start date | 24 May 2023 |
| Primary completion | 24 May 2028 |
| Estimated completion | 24 May 2028 |
| Sites | 1 location across France |
Drugs / interventions tested
- Sublingual videomicroscopy
- blood sample — full drug profile →
Conditions studied
- Von Willebrand Diseases — all drugs for Von Willebrand Diseases →
- Glanzmann Thrombasthenia — all drugs for Glanzmann Thrombasthenia →
Sponsor
University Hospital, Lille
Who can join
18 and older, any sex, with Von Willebrand Diseases or Glanzmann Thrombasthenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In Willebrand disease, there is currently no test available to identify non-invasively patients with a high risk of bleeding from angiodysplasias The study propose to use a sublingual capillary bed analysis by video-microscopy, a sensitive, reproducible and non-invasive technique, to assess whether sublingual capillary density is predictive of hemorrhagic risk for patients with von Willebrand disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
Shi Y, Tang D, Li X, Xie X, et al · · 2022 · cited 10× · PMID 35677161 · DOI 10.3389/fonc.2022.889034
Verify or expand the search:
- PubMed search for NCT04119908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Von Willebrand Diseases
Currently open trials in the same condition.
- NCT05773638 — Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West · recruiting
- NCT03853486 — ATHN 9: Severe VWD Natural History Study · active not recruiting
Other University Hospital, Lille trials
Trials by the same sponsor.
- NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
- NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
- NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
- NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
- NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04119908 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04119908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing